title: Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Flores
authors.forename: Israel
authors.initials: I
authors.lastname: Alvarado
authors.forename: Ma-Li
authors.initials: ML
authors.lastname: Wong
authors.forename: Julio
authors.initials: J
authors.lastname: Licinio
authors.forename: David
authors.initials: D
authors.lastname: Flockhart
mesh_terms: D000328:Adult; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D003863:Depression / Q000188:drug therapy* / Q000208:ethnology; D003891:Desipramine / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D017058:Mexican Americans / Q000235:genetics*; D008875:Middle Aged; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D013610:Tachycardia / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
chemical_list: D005473:Fluoxetine; D019389:Cytochrome P-450 CYP2D6; D003891:Desipramine